We are live on ! Find out more
BCM

Blume Capital Management Portfolio holdings

AUM $684M
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+41.68%
3 Year Est. Return
+96.87%
5 Year Est. Return
+108.87%
10 Year Est. Return
+366.52%
AUM
$166M
AUM Growth
+$3.17M
Cap. Flow
-$1.3M
Cap. Flow %
-0.78%
Top 10 Hldgs %
44.41%
Holding
217
New
17
Increased
28
Reduced
43
Closed
7

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$3.32M
2
KMI icon
Kinder Morgan
KMI
+$1.51M
3
AGN
Allergan plc
AGN
+$1.03M
4
CMCSA icon
Comcast
CMCSA
+$369K
5
VOD icon
Vodafone
VOD
+$168K

Top Sells

Rank Stock Value
1
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$2.51M
2
TWX
Time Warner Inc
TWX
+$1.82M
3
BKNG icon
Booking.com
BKNG
+$1.78M
4
QCOM icon
Qualcomm
QCOM
+$1.55M
5
MSFT icon
Microsoft
MSFT
+$155K

Sector Composition

Rank Sector Weight
1 Technology 18.39%
2 Energy 18.15%
3 Financials 14.33%
4 Healthcare 12.43%
5 Communication Services 11.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DEO icon
151
Diageo
DEO
$49B
$14K 0.01%
133
– –
KMB icon
152
Kimberly-Clark
KMB
$36.3B
$14K 0.01%
120
– –
HAPN
153
Happen Inc
HAPN
$2.21B
$14K 0.01%
540
– –
NEM icon
154
Newmont
NEM
$98.7B
$14K 0.01%
405
– –
ARCC icon
155
Ares Capital
ARCC
$13.5B
$13K 0.01%
800
-500
-38% -$7.87K
MO icon
156
Altria Group
MO
$114B
$13K 0.01%
185
– –
NYT icon
157
New York Times
NYT
$12.1B
$13K 0.01%
1,000
– –
SCHW
158
Charles Schwab
SCHW
$183B
$13K 0.01%
342
– –
GSK icon
159
GSK
GSK
$104B
$11K 0.01%
226
– –
CSQ icon
160
Calamos Strategic Total Return Fund
CSQ
$3.23B
$10K 0.01%
1,000
– –
DNP icon
161
DNP Select Income Fund
DNP
$4.05B
$10K 0.01%
1,000
– –
TTNP
162
DELISTED
Titan Pharmaceuticals
TTNP
$10K 0.01%
1
– –
P
163
DELISTED
Pandora Media Inc
P
$10K 0.01%
750
– –
WY icon
164
Weyerhaeuser
WY
$18B
$9K 0.01%
296
– –
OKS
165
DELISTED
Oneok Partners LP
OKS
$9K 0.01%
200
– –
DRRX
166
DELISTED
DURECT Corp
DRRX
$8K ﹤0.01%
600
– –
KIM icon
167
Kimco Realty
KIM
$17.2B
$8K ﹤0.01%
300
– –
NVCR icon
168
NovoCure
NVCR
$1.73B
$8K ﹤0.01%
1,000
– –
PCG icon
169
PG&E
PCG
$38.3B
$8K ﹤0.01%
129
+1
+0.8% +$60
UDR icon
170
UDR
UDR
$12.3B
$8K ﹤0.01%
216
– –
UL icon
171
Unilever
UL
$137B
$8K ﹤0.01%
178
– –
CFMS
172
DELISTED
Conformis, Inc. Common Stock
CFMS
$8K ﹤0.01%
40
– –
BF.A icon
173
Brown-Forman Class A
BF.A
$13.4B
$7K ﹤0.01%
200
– –
INO icon
174
Inovio Pharmaceuticals
INO
$55.7M
$7K ﹤0.01%
83
– –
RWT
175
Redwood Trust
RWT
$574M
$7K ﹤0.01%
448
– –
5 6
7
8 9

Similar funds

HCP
Hexagon Capital Partners Rogers, Arkansas $683M AUM 34.85% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $685M AUM 15.32% 1-Year Est. Return
HWM
Horizon Wealth Management La Grange, Illinois $682M AUM 25.04% 1-Year Est. Return
ECM
Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return
DMC
Drexel Morgan & Co Radnor, Pennsylvania $682M AUM 21.01% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return

Blume Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Blume Capital Management held 217 positions worth $166M, up 1.9% from $163M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Blume Capital Management's Q4 2016 filing shows 17 new, 28 increased, 43 reduced and 7 closed positions. Its largest new stake was Teva Pharmaceuticals: 83,115 shares worth $3.01M. The largest sale was Vanguard Short-Term Corporate Bond ETF, an estimated $2.51M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Energy and Financials.

  • Blume Capital Management's largest Q4 2016 buy was Teva Pharmaceuticals: 83,115 shares worth $3.01M.
  • Blume Capital Management added most to Kinder Morgan in Q4 2016, an estimated $1.51M increase.
  • Blume Capital Management's biggest Q4 2016 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $2.51M.
  • Blume Capital Management fully exited Gen Digital in Q4 2016, selling an estimated $64K.
  • Blume Capital Management's ten largest holdings make up 44% of its $166M portfolio in Q4 2016.
  • Blume Capital Management opened 17 new positions and closed 7 in Q4 2016.
  • Blume Capital Management's portfolio value rose 1.9% quarter-over-quarter to $166M.

Based on Blume Capital Management's 13F filing for Q4 2016, filed 30 Jan 2017.